N Latex FLC kappa and lambda assays
4 November 2022
N Latex FLC assays from Siemens Healthineers can be used to determine levels of serum FLC kappa and lambda in patients with plasma-proliferative disorders and in the monitoring of these diseases. It has been proven that FLC determination can assist in monitoring therapy success, as well as providing prognostic information. In this review of N Latex FLC kappa and lambda assays, Siemens Healthineers presents a selection of papers related to the use of N Latex FLC assays in cases of multiple myeloma, amyloidosis, kidney disease, multiple sclerosis, and other neurological disorders. The papers included here provide a review of the guidelines and utility in diagnoses of the N Latex FLC assays, and also touch on methodological aspects of FLC quantification.